Immunovia appoints new Senior Director Investor Relations and Corporate Communications
LUND, SWEDEN – Immunovia AB (publ) announces that Tobias Bülow has been appointed new Senior Director Investor Relations and Corporate Communications, taking up his position January 15. Tobias has s solid IR and Corporate Communications background with extensive experience from international high-tech companies. Tobias joins Immunovia from Mycronic AB (publ), where he most recently held the position of Director Investor Relations. Previous experiences include Director Financial Communications at the radiation therapy company Elekta AB (publ). “I am very pleased to welcome